🇺🇸 FDA
Patent

US 9624238

4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use

granted A61PA61P19/10A61P43/00

Quick answer

US patent 9624238 (4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use) held by LEXICON PHARMACEUTICALS, INC. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P19/10, A61P43/00